A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Risk of early death after treatment with curative intent for head and neck squamous cell carcinoma: a retrospective population-based study
Tekijät: Bazina, Mahmoud; Nikkilä, Rayan; Haapaniemi, Aaro; Bäck, Leif; Ventelä, Sami; Mäkitie, Antti
Kustantaja: MJS Publishing, Medical Journals Sweden AB
Kustannuspaikka: Uppsala
Julkaisuvuosi: 2025
Journal: Acta Oncologica
Tietokannassa oleva lehden nimi: Acta Oncologica
Lehden akronyymi: ACTA ONCOL
Vuosikerta: 64
Aloitussivu: 339
Lopetussivu: 348
Sivujen määrä: 10
ISSN: 0284-186X
eISSN: 1651-226X
DOI: https://doi.org/10.2340/1651-226X.2025.42202
Verkko-osoite: https://doi.org/10.2340/1651-226x.2025.42202
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/491573449
Background and purpose:
Knowledge regarding the risk factors for early death in patients with head and neck squamous cell carcinoma (HNSCC) is scarce. This study aims to evaluate the rate of early death (during or within 6 months of treatment) and its associated risk factors in HNSCC patients treated with curative intent.
Materials and methods:
A retrospective, population-based analysis of all HNSCC patients (n = 762) treated with curative intent at the Helsinki University Hospital (Helsinki, Finland) during 2012-2015 was conducted. Using the chi-square test, associations between categorical variables were assessed. Univariate and multivariate analyses were performed to identify independent factors for early death.
Results:
The rate of early death was 10.1% with a median age of 70 years at diagnosis. Advanced stage, smoking > 40 pack-years, and heavy alcohol consumption were associated with increased odds of early death. Elevated thrombocyte levels > 380 (x 109L) were observed more frequently in the early-death group when comparing the levels with the late-death group (p < 0.01). However, only age (odds ratio [OR] 1.05; 95% confidence interval [CI]:1.02-1.08), T4 class (OR 5.98; 95% CI: 2.60-13.74), N2 class (OR 2.98; 95% CI: 2.60-13.74), and N3 class (OR 12.24; 95% CI: 2.99-50.19) emerged as independent risk factors for early death.
Interpretation:
Early death risk is increased in older patients and those with advanced-stage HNSCC. Elevated thrombocyte count requires further studies to assess its utility as a potential clinical marker.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This study was supported by the State Research Funding for the Helsinki University Hospital and the Sigrid Jusélius Foundation.